eve Conference Variant Block
By position
CEO/President/Managing Director
Chief Scientist/Chief Operating Officer
Antibody researcher/R&D director
Director, research and development/scientific
Senior scientist/Director of the Institute
Line manager/Director of regulatory affairs
Safety/Quality control supervisor
IT data management officer
Expert on venture capital
Business development director
Lawyer/Consultant/Analyst with pharmaceutical background
By industry
Pharmaceutical CROs
Pharmaceuticals
Biotechnology
Pharmaceutical relevant policy & regulation agency
Pharmaceutical association
University/Institute
Antibody R&D platform service supplier
Protein technology provider
Laboratory equipment supplier
Logistics
Venture Capital
Legal / tax / financial consultancy
Package Plan
Before 29/2/2012: USD 440
After 29/2/2012: USD 540
eve Conference Detail Testimonial
Chinese companies and academics reaching out to the western scientific community through attending meetings, publishing in scientific journals, etc is very important to address this problem. By not publishing more it is not only hurting China's growth but global growth as the opportunity to collaborate on research and find out about new discoveries is limited.
——Seth Goldenberg, President of Asia Pacific Bio Intelligence LLC
